Oxytocin is a nonapeptide hormone and neuroregulatory peptide widely investigated in receptor binding assays, smooth-muscle cellular models, and neuroendocrine signaling pathways. This technical reference manual outlines the precise oxytocin MW, chemical formula, structural configuration, and high-performance analytical verification standards required for rigorous preclinical research.
Oxytocin is a nonapeptide hormone and neuroregulatory peptide widely investigated in receptor binding assays, smooth-muscle cellular models, and neuroendocrine signaling pathways. This technical reference manual outlines the precise oxytocin MW, chemical formula, structural configuration, and high-performance analytical verification standards required for rigorous preclinical research.
The molecular weight of oxytocin (commonly referenced in scientific literature as oxytocin MW) is 1007.19 g/mol (Da), with a monoisotopic mass of 1006.44 Da. Its precise empirical molecular formula is C43H66N12O12S2. Oxytocin is structurally classified as a cyclic nonapeptide featuring a distinct six-amino-acid disulfide ring and a three-amino-acid C-terminal tail ending in an amidated glycine residue.
In analytical assays, understanding the exact molecular weight is critical for calculating precise molar concentrations during buffer preparation, receptor binding kinetics, and liquid chromatography-mass spectrometry (LC-MS) evaluations. Researchers procuring high-purity reference standards must account for both the target peptide mass and potential counter-ion adducts (such as trifluoroacetate) when calculating working solution stoichiometry for cell culture or enzymatic assays.
The primary structure of oxytocin consists of nine amino acid residues linked in the following single-letter and three-letter sequence: H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (or C-Y-I-Q-N-C-P-L-G-NH2). A intra-molecular disulfide bridge forms between the cysteine residues at positions 1 and 6 (Cys1–Cys6), creating a rigid 20-membered covalent ring that is essential for receptor binding affinity.
The presence of the disulfide bridge alters the spatial conformation of the N-terminal ring, projecting the tyrosine residue at position 2 and isoleucine at position 3 into specific hydrophobic pockets of the target receptor. Modifying or reducing this disulfide linkage results in a complete loss of biological activity in vitro. For comparative structural studies involving altered peptide backbones, explore our documentation on the oxytocin sequence and related nonapeptide motifs across our research library.
To verify oxytocin MW and confirm chemical identity, laboratory verification relies on electrospray ionization mass spectrometry (ESI-MS) combined with reverse-phase high-performance liquid chromatography (RP-HPLC). Under positive ionization ESI-MS conditions, the single protonated adduct [M+H]+ appears at m/z 1008.2, while multiply charged ions or dimer traces are evaluated to ensure batch homogeneity.
Analytical RP-HPLC profiles for research-grade oxytocin peptide typically utilize C18 hydrophobic stationary phases with an acetonitrile/water gradient containing 0.1% trifluoroacetic acid (TFA). A single symmetrical chromatographic peak corresponding to >98.0% chemical purity confirms the absence of truncated sequences, uncyclized linear intermediates, or oxidized species. Full analytical reports, including raw spectra and HPLC chromatograms, are provided on the lot-specific Certificate of Analysis (COA) for all items in our all peptides catalog.
Oxytocin belongs to the evolutionary conserved neurohypophyseal peptide family, sharing significant structural homology with vasopressin and long-acting synthetic analogs. Comparing the physicochemical parameters of these compounds demonstrates how minor amino acid substitutions dramatically shift molecular weight, receptor selectivity, and metabolic stability in experimental models.
For instance, arginine vasopressin (AVP) differs from oxytocin by possessing a phenylalanine at position 3 and an arginine at position 8, yielding a molecular weight of 1084.24 g/mol compared to the lower oxytocin MW of 1007.19 g/mol. Conversely, carbetocin is a modified oxytocin analog featuring a thioether bridge instead of a disulfide bond and an N-terminal modification, giving it a molecular mass of 988.17 g/mol and enhanced enzymatic resistance in vitro. The structural parameters of these related research compounds are summarized below:
Oxytocin functions primary as a selective agonist at the oxytocin receptor (OXTR), a class A Rhodopsin-like G-protein coupled receptor (GPCR). Preclinical studies suggest that agonist binding triggers a conformational shift in OXTR, stimulating the Gq/11 signaling cascade. This activation prompts phospholipase C-beta (PLC-β) to hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).
Subsequent IP3 binding to receptors on the sarcoplasmic/endoplasmic reticulum induces rapid intracellular calcium ion (Ca2+) mobilization. In smooth-muscle cell models and neuroendocrine tissue slices, elevated cytosolic calcium binds calmodulin, activating myosin light-chain kinase (MLCK) and initiating cellular contraction or neurotransmitter release. In vitro research also demonstrates that OXTR signaling can cross-activate MAPK/ERK and PI3K/Akt signaling pathways depending on receptor density and cell lineage.
In academic and pharmaceutical research, synthetic oxytocin serves as a benchmark tool across several primary experimental domains:
1. Smooth-Muscle Cell Models: Applied to cultured myometrial and mammary myoepithelial cells to quantify calcium flux, contractility dynamics, and receptor desensitization kinetics. 2. Neuroendocrine and Behavioral Circuitry: Used in rodent brain slice preparations and primary neuronal cultures to evaluate synaptic transmission, GABA/glutamate balance, and social attachment signaling pathways. 3. Receptor Binding and Affinity Assays: Employed in competitive radioperfused or fluorescent ligand binding studies to map OXTR binding pockets and measure dissociation constants (Kd). 4. Cross-Reactivity Mapping: Utilized to test selectivity against vasopressin receptor subtypes (V1a, V1b, V2) in recombinant cell lines.
When sourcing peptides for high-throughput screening or quantitative binding assays, lot-to-lot consistency and rigorous analytical verification are mandatory. PX1 Research adheres to strict laboratory standards to ensure every batch of oxytocin meets exact specifications for molecular weight, sequence fidelity, and purity.
Our quality assurance framework includes the following core criteria: • USA-Manufactured: Produced in domestic, state-of-the-art laboratory facilities adhering to GMP-compliant processes. • HPLC/MS Purity Verification: Every lot is analyzed via RP-HPLC and ESI-MS to confirm >98.0% purity and verify the theoretical oxytocin MW. • Endotoxin Testing: Verified to contain <0.01 EU/mg via chromogenic LAL assays, mitigating confounding inflammatory responses in cell culture. • Third-Party COA per Lot: Independent ISO 17025 accredited laboratory testing documentation accompanies every shipment. • Comprehensive Lot Traceability: Complete audit trails from automated solid-phase peptide synthesis (SPPS) through lyophilization. • Rapid Logistics: Orders are packed under inert nitrogen atmospheres and ship same-day M–F from our centralized distribution hubs in CA and AZ.
To maintain structural integrity and prevent premature disulfide bond cleavage or oxidation, standard laboratory handling procedures must be observed during reconstitution. Oxytocin is highly soluble in sterile aqueous buffers such as phosphate-buffered saline (PBS, pH 7.4), 0.9% sodium chloride, or sterile deionized water.
To prepare a 1 mM stock solution using a 5 mg vial of oxytocin: 1. Determine the exact mass of the peptide vial using the COA net weight (e.g., 5.00 mg). 2. Calculate the required solvent volume using the formula: Volume (L) = Mass (g) / (Molar Mass (g/mol) × Desired Molarity (mol/L)). 3. For 5.00 mg (0.005 g) at an oxytocin MW of 1007.19 g/mol: Volume = 0.005 / (1007.19 × 0.001) = 0.00496 L, or 4.96 mL of buffer. 4. Gently invert or swirl the vial until complete dissolution is achieved. Avoid high-shear vortexing, which may introduce mechanical stress or foaming.
For complex experimental setups requiring precise dilution matrices, consult our analytical guides on the PX1 research hub or review bulk ordering parameters via our wholesale accounts portal.
Lyophilized oxytocin powder should be stored desiccated at -20°C or -80°C upon arrival, protected from direct light exposure. Under these ultra-low temperature conditions, the dry peptide remains stable for up to 24 months without significant degradation or oxidation of the disulfide bridge.
Once reconstituted into aqueous stock solutions, the working peptide should be divided into single-use laboratory aliquots using low-binding polypropylene microcentrifuge tubes. Store aliquots at -80°C to prevent degradation. Repeated freeze-thaw cycles must be strictly avoided, as thermal cycling promotes peptide aggregation and hydrolytic cleavage of the C-terminal amide group.
What is the exact oxytocin mw?
The precise molecular weight (oxytocin MW) is 1007.19 g/mol (Da). Its monoisotopic mass is 1006.44 Da, corresponding to the empirical chemical formula C43H66N12O12S2.
What is the primary amino acid sequence of oxytocin?
The sequence of oxytocin is Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, featuring an intramolecular disulfide bridge between the Cys1 and Cys6 residues.
How does oxytocin MW compare to vasopressin MW?
Oxytocin has a molecular weight of 1007.19 Da, whereas arginine vasopressin (AVP) has a molecular weight of 1084.24 Da due to amino acid substitutions (Phe3 and Arg8 in AVP versus Ile3 and Leu8 in oxytocin).
Why is the disulfide bridge critical for oxytocin function in vitro?
The Cys1–Cys6 disulfide bond creates a rigid 20-membered ring that locks the N-terminal amino acids into the correct spatial conformation required to bind and activate the oxytocin receptor (OXTR).
How is oxytocin MW verified by PX1 Research?
PX1 Research verifies oxytocin MW using Electrospray Ionization Mass Spectrometry (ESI-MS), confirming the predicted [M+H]+ parent ion peak at m/z 1008.2 alongside RP-HPLC purity assessment.
What solvents are recommended for reconstituting oxytocin for research?
Oxytocin lyophilized powder dissolves readily in sterile deionized water, 0.9% sterile saline, or phosphate-buffered saline (PBS, pH 7.4). For working stock solutions, use sterile polypropylene containers.
What is the endotoxin limit for PX1 Research oxytocin?
Every lot of PX1 Research oxytocin is tested via chromogenic LAL assays to ensure endotoxin levels remain below 0.01 EU/mg, preventing false positive inflammatory signaling in cell culture models.
Can reconstituted oxytocin undergo multiple freeze-thaw cycles?
No. Freeze-thaw cycles cause physical stress that can disrupt the disulfide bond and lead to aggregation. Reconstituted stock solutions should be aliquoted and frozen at -80°C for single use.
What analytical documents are provided with PX1 oxytocin orders?
Every shipment includes a lot-specific Certificate of Analysis (COA) containing raw RP-HPLC chromatograms, ESI-MS spectra, mass verification, and endotoxin assay results.
Does PX1 Research offer bulk oxytocin for institutional laboratories?
Yes, PX1 Research provides custom quantities, high-throughput screening supplies, and volume pricing for institutional research programs through our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.